Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

TraumaCad Sales Cement Brainlab Position as UK Market Leader for Orthopedic Surgical Planning

Brainlab
Posted on: 29 Sep 16

LONDON--(BUSINESS WIRE)--

Brainlab, a global leader in medical technology, announced today that it has solidified its position as the dominant force in orthopedic surgical planning, adding 20 new TraumaCad® sites in the United Kingdom in the past 12 months. With consistent annual sales growth in the U.K. of approximately 10 percent, TraumaCad is now available in nearly 70 percent of hospitals in the U.K.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160928005088/en/

“Before we started using TraumaCad, in January 2016, my colleagues and I were well aware of its excellent reputation amongst our colleagues elsewhere,” said Simon Royston, Sheffield Teaching Hospitals, NHS Trust. “We have found it very intuitive to use and it has been a step-up in the ease and quality of our pre-operative planning. The training and technical support from Brainlab has been superb, all the way from pre-installation to the present.”

Installed at over 2,000 locations worldwide, TraumaCad surgical planning by Brainlab, provides orthopedic surgeons with a comprehensive digital solution for performing pre-operative planning and simulations. The procedure-oriented application includes an extensive digital template library and offers a full set of wizards and measurement tools. Using digital images, surgeons can perform measurements, assess prostheses, simulate osteotomies, and visualize fracture reductions.

“Our explosive growth in TraumaCad sales is not only a great validation of the quality and reputation of our technology, but it is also an important recognition of the growing demand for hospitals and clinics to stay ahead of the curve in orthopedic treatments,” said Ian Wilson, Sales Manager, on behalf of Brainlab. “In most cases, the UK hospitals and clinics that have purchased TraumaCad in the past year or two have replaced other digital templating solutions.”

For more information on TraumaCad, visit www.traumacad.com

About Brainlab

Brainlab, headquartered in Munich develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 11,000 systems installed in about 100 countries. Brainlab employs 1,350 people in 19 offices worldwide, including 385 Research & Development engineers, who form a crucial part of the product development team.

For more information:
finance.yahoo.com/news/traumacad-sales-cement-brainlab-position-070000560.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 29/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.